Phenotype, Genotype & Biomarkers in ALS and Related Disorders
This study is being done to find out how adding chemotherapy to hormonal therapy affects the quality and length of life in patients with advanced prostate cancer. The researchers hope to learn whether receiving docetaxel both when start hormone therapy (or within 120 days of beginning hormonal therapy) as well as when disease worsens, is better than only receiving docetaxel when disease gets worse. This trial will let us know which approach is more effective in treating the disease.
The US Food and Drug Administration (FDA) considers the use of docetaxel to be investigational (experimental for treating advanced prostate cancer).